Ronald Shuang

Mr. Ronald Shuang is responsible for deal origination, investment analysis, valuation, negotiation, and initial public offerings of the portfolio companies.
Prior to joining Infinity Equity, Ronald Shuang gained over 16 years of experience in advising China-bound investments, mergers & acquisitions, post M&A integrations, and market entry/growth strategies in both US and Chinese markets working for Cap Gemini US LLC, McKinsey & Company, Pfizer, etc.
Ronald Shuang received an MBA in Finance from the University of Michigan, Ann Arbor.
He also holds a Master degree in Healthcare Management and Policy from Harvard University and a Bachelor degree from Wuhan University, China.